16 insiders have filed at NHI since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Adams W Andrew | Director | 1.02M | 2.097% | ||
| Adams Robert G | Director | 566.6k | 1.167% | ||
| Mendelsohn D. Eric | CEO And President | 132.2k | 0.272% | ||
| Swafford Charlotte A | Director | 127.4k | 0.262% | 1 buys $587k | |
| Webb Robert T | Director | 123.0k | 0.253% | ||
| Gaines Kristin Sallee | SVP/Chief Transaction Officer | 73.8k | 0.152% | ||
| Pascoe Kevin Carlton | Chief Investment Officer | 73.4k | 0.151% | ||
| Spaid John L | CFO/EVP Finance | 56.3k | 0.116% | ||
| Mccabe Robert A JR | Director | 43.3k | 0.089% | 1 buys $29k | |
| Travis David L | SVP/Chief Accounting Officer | 40.8k | 0.084% | ||
| Jobe James R | Director | 35.3k | 0.073% | 1 buys $51k | |
| Colden Tracy M J | Director | 12.9k | 0.026% | ||
| Todd Candice W | Director | 2.6k | <0.01% | ||
| Blankenship Elizabeth Jackson | SVP, Legal Affairs | 2.4k | <0.01% | ||
| Donohue Lilly | Director | 1.3k | <0.01% | ||
| Chapin Robert | Director | 1.3k | <0.01% |
Full register at boothcheck.com/insiders/NHI. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.